Mayukh Sukhatme, President & CIO at Roivant Sciences Ltd. (ROIV), sold 664,826 shares at $36.23 ($24.2M) on 2026-08-14, disclosed to the SEC on 2026-08-18.
Open-market sale of $24.2M ROIV by President & CIO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.23 | 243,177 | $8.8M | 36.5% |
| 2 | $36.25 | 284,707 | $10.3M | 42.7% |
| 3 | $36.59 | 105,141 | $3.8M | 15.9% |
| 4 | $37.18 | 31,801 | $1.2M | 4.9% |
| Total | $36.34 avg | 664,826 | $24.2M | 100% |
| Filing → |
| ROIV | SELL | 2026-02-11 | $9.0M | — | Filing → |
| ROIV | SELL | 2025-12-31 | $57.8M | — | Filing → |
| ROIV | SELL | 2025-12-19 | $1.2M | — | Filing → |